Stanford professor James Zou examined the clinical adoption of medical AI devices, and found that only a handful are being ...

Opinion: “Exposed” by Wendy Kline shows how the pelvic exam exemplifies questions about gender, medicine, and power.

Health care stocks stumbled compared with the rest of the market in 2023. Companies missed their profit targets. Some CEOs ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...

Antimicrobial resistance is a threat to modern medicine, writes WHO’s Director-General. But a sign of hope emerged at the U.N. General Assembly.

The CDC said an investigation into a human H5N1 bird flu infection in Missouri has found four additional health care workers ...

Dupixent, commonly used to treat eczema and asthma, was cleared for a subset of patients with chronic obstructive pulmonary disease.

What comes next for Pfizer's Oxbryta sickle cell drug —Cassava Sciences' SEC charges —Bristol's new schizophrenia treatment ...

Medicare’s controversial decision to condition coverage for even fully approved Alzheimer’s drugs is here to stay, per a top ...

A dispute over a Duchenne gene therapy highlights thorny issues surrounding FDA approvals and insurance policies.

Dhillon is an instructor in the Division of Global Health Equity at Brigham and Women’s Hospital and Harvard Medical School.